https://smallcaps.com.au/article/pharmaust-monepantel-trials-move-to-phase-iii-significant-anti-cancer-results
PharmAust’s monepantel trials to move to phase III after significant anti-cancer results
Jun 28, 2021 - PharmAust Limited’s (ASX: PAA) clinical trials testing anti-cancer drug monepantel in canine lymphoma has successfully achieved phase two primary endpoints...
phase iiimonepanteltrialsmovesignificant